Publication | Closed Access

IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release

Igm Monoclonal AntibodyPure MotorAmyotrophic Lateral SclerosisAutoimmune DiseaseNeurological DisorderMedicineImmunologyTerminal MoietyNeurologyNeuroscienceMultiple SclerosisCommon Neurological DisordersPeripheral NervesNeuroimmunologyNeuropathology